A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition
BMC » Health Economics Review
by Richard C. van Kleef, Mieke Reuser, Pieter J.A. Stam and Wynand P.M.M. van de Ven
2d ago
Many health insurance markets are organized by principles of regulated competition. Regulators of these markets typically apply risk equalization (aka risk adjustment) and risk sharing to mitigate risk selecti ..read more
Visit website
Cost of illness of breast cancer in low- and middle-income countries: a systematic review
BMC » Health Economics Review
by Siew Wei Yeong, Sit Wai Lee and Siew Chin Ong
4d ago
This systematic review explores the cost of illness (COI) studies on breast cancer in low- to middle-income countries (LMICs). Studies in Cochrane, Proquest Thesis, PubMed and Scopus were considered. The repor ..read more
Visit website
A decade of liver transplantation in Mongolia: Economic insights and cost analysis
BMC » Health Economics Review
by Amarjargal Tsengel, Sergelen Orgoi, Otgonbayar Damdinbazar, Bat-Ireedui Badarch, Urnultsaikhan Ganbold, Batsaikhan Batsuuri, Yerkyebulan Mukhtar, Batsaikhan Bat-Erdene, Liu Lei, Tserenbat Bazarsad, Undarmaa Zandanbazar and Gantugs Yundendorj
1w ago
Mongolia introduced liver transplantation 10 years ago, becoming the 46th country globally to successfully perform this procedure. However, the cost of liver transplantation treatment remains expensive in Mong ..read more
Visit website
Has China’s hierarchical medical system improved doctor-patient relationships?
BMC » Health Economics Review
by Yang Gao, Yang Yang, Shoupeng Wang, Wenqian Zhang and Jiao Lu
1w ago
Developing harmonious doctor-patient relationships is a powerful way to promote the construction of a new pattern of medical reform in developing countries. We aim to analyze the effects of China’s hierarchica ..read more
Visit website
Economic analysis of digital motor rehabilitation technologies: a systematic review
BMC » Health Economics Review
by Koffi Adzinyo Agbemanyole, Kokouvi Geovani Agbohessou, Christelle Pons, Philippe Lenca, Olivier Rémy-Néris and Myriam Le Goff-Pronost
1w ago
Rehabilitation technologies offer promising opportunities for interventions for patients with motor disabilities. However, their use in routine care remains limited due to their high cost and persistent doubts ..read more
Visit website
Insured-non-insured disparity of catastrophic health expenditure in Northwest Ethiopia: a multivariate decomposition analysis
BMC » Health Economics Review
by Yawkal Tsega, Gebeyehu Tsega, Asnakew Molla Mekonen, Tesfaye Birhane, Elsabeth Addisu, Abebe Getie, Fekade Demeke Bayou, Mulugeta Desalegn Kasaye, Natnael Kebede and Amare Muche
1w ago
Financial risk protection is one indicator of universal health coverage (UHC). All people should be protected from financial risks such as catastrophic health expenditures (CHE) to ensure equitable health serv ..read more
Visit website
Social costs associated with fibromyalgia in Spain
BMC » Health Economics Review
by J Oliva-Moreno and C Vilaplana-Prieto
1w ago
Fibromyalgia is a chronic rheumatic disease of unknown aetiology, highly disabling and mainly affecting women. The aim of our work is to estimate, on a national scale, the economic impact of this disease on th ..read more
Visit website
Untangling the corruption maze: exploring the complexity of corruption in the health sector
BMC » Health Economics Review
by Margit Sommersguter-Reichmann and Gerhard Reichmann
1w ago
Healthcare corruption poses a significant threat to individuals, institutions, sectors, and states. Combating corruption is paramount for protecting patients, maintaining the healthcare system's integrity, and ..read more
Visit website
Correction: A microcosting approach for planning and implementing community‑based mental health prevention programs: what does it cost?
BMC » Health Economics Review
by Sharmily Roy, Henry Shelton Brown III, Lisa Sanger Blinn, Sarah Carter Narendorf and Jane E. Hamilton
2w ago
..read more
Visit website
Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review
BMC » Health Economics Review
by Hongyu Gong, Siew Chin Ong, Fan Li, Yan Shen, Zhiying Weng, Keying Zhao, Zhengyou Jiang and Meng Wang
3w ago
Since 2017, immune checkpoint inhibitors (ICIs) have been available for the treatment of advanced hepatocellular carcinoma (HCC) or unresectable HCC, but their adoption into national medical insurance programs ..read more
Visit website

Follow BMC » Health Economics Review on FeedSpot

Continue with Google
Continue with Apple
OR